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A64-year-old Caucasian male who had percutaneous closure of a patent formaen ovale(PFO) presented for follow-up 2 years later.A shows a transesophageal echocardiogram (TEE) of: 1) a left atrial (LA) mass; 2)
the LA mass arising from the atrial septal defect (ASD) closure device; and 3) the protrusion
of the mass into the left ventricle (LV). The mass was large and hyper mobile, flopping into the
mitral inflow tract consistent with a thrombus versus a myxoma. Surgical excision was indicated
given the size, mobility, and danger of embolization. B shows a: 1) 6  5.5  1.5 cm brownish
gelatinous mass; 2) amplatzer device; and 3) the site of attachment to the ASD/PFO closure de-
vice. Histopathological analysis confirmed myxoma. C shows TEE at the time of original diagnosis
of PFO; no mass was noted in the LA.
This case represents a surprising outcome of a surveillance TEE (Online Video 1) fol-
lowing percutaneous ASD closure. Previous case reports have described myxoma growth
rates of up to 2.2 mm/month (1). The growth rate in this case was 2.5 mm/month, sug-
gesting that growth rate alone is not an adequate distinguishing feature for thrombus ver-
sus myxoma.
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